These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8907208)

  • 21. Program on the Surgical Control of the Hyperlipidemias (POSCH): design and methodology. POSCH Group.
    Buchwald H; Matts JP; Fitch LL; Varco RL; Campbell GS; Pearce M; Yellin A; Smink RD; Sawin HS; Campos CT
    J Clin Epidemiol; 1989; 42(12):1111-27. PubMed ID: 2685177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-degree kinship with young coronary artery disease patients markedly increases lipid-level disorders in asymptomatic hypertensives.
    Giannini SD; Diament J; Forti N; Issa JS; Dal Bó C; Fukushima J; Barretto AC
    J Cardiovasc Risk; 1998 Jun; 5(3):141-5. PubMed ID: 10201549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease.
    Mack MJ; Pfister A; Bachand D; Emery R; Magee MJ; Connolly M; Subramanian V
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):167-73. PubMed ID: 14752427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol consumption, atherosclerotic progression, and prognosis among patients with coronary artery bypass grafts.
    Mukamal KJ; Girotra S; Mittleman MA
    Am Heart J; 2006 Feb; 151(2):368-72. PubMed ID: 16442902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein modification achieved by partial ileal bypass: five-year results of The Program on the Surgical Control of the Hyperlipidemias.
    Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
    Surgery; 1987 Aug; 102(2):424-32. PubMed ID: 3303402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.
    Carrier M; Ménasché P; Levy JH; Newman MF; Taylor KM; Haverich A; Chen JC; Shernan SK; Van de Werf F; van der Laan M; Todaro TG; Adams PX; Verrier ED
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):352-6. PubMed ID: 16434264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery.
    Brener SJ; Lytle BW; Casserly IP; Ellis SG; Topol EJ; Lauer MS
    Eur Heart J; 2006 Feb; 27(4):413-8. PubMed ID: 16272211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group.
    Buchwald H; Matts JP; Fitch LL; Campos CT; Sanmarco ME; Amplatz K; Castaneda-Zuniga WR; Hunter DW; Pearce MB; Bissett JK
    JAMA; 1992 Sep; 268(11):1429-33. PubMed ID: 1512911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perception of quality of life before and after disclosure of trial results: a report from the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Fitch LL; Matts JP; Johnson JW; Hansen BJ; Stuenkel MR; Brooks HB
    Control Clin Trials; 1993 Dec; 14(6):500-10. PubMed ID: 8119065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Apr; 117(4):511-5. PubMed ID: 15109440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N; Wijns W; Serruys PW; Sigwart U; Flather MD; Stables RH; O'Neill WW; Rodriguez A; Lemos PA; Hueb WA; Gersh BJ; Booth J; Boersma E
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of lifestyle changes on atherogenic lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease.
    Tonstad S; Sundfør T; Seljeflot I
    Am J Cardiol; 2005 May; 95(10):1187-91. PubMed ID: 15877991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of bypass surgery and stenting for the treatment of multivessel disease: results from the ARTS trial in Israel.
    Gruberg L; Milo S; Ben Tzvi M; Lotan C; Merin G; Braun S; Mohr R; Tzivoni D; Bitran D; Beyar R;
    Isr Med Assoc J; 2003 Aug; 5(8):539-42. PubMed ID: 12929288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting.
    Novaro GM; Pearce GL; Sprecher DL; Griffin BP
    J Heart Valve Dis; 2001 Jan; 10(1):19-24. PubMed ID: 11206763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of coronary bypass grafting in a population of middle-aged men.
    Dudas KA; Wilhelmsen L; Rosengren A
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):122-7. PubMed ID: 17301637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary artery surgery study (CASS): a randomized trial of coronary bypass surgery. Eight years follow-up and survival in patients with reduced ejection fraction.
    Killip T; Passamani E; Davis K
    Circulation; 1985 Dec; 72(6 Pt 2):V102-9. PubMed ID: 3905050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarction.
    Matts JP; Buchwald H; Fitch LL; Campos CT; Varco RL; Campbell GS; Pearce MB; Yellin AE; Smink RD; Sawin HS
    J Clin Epidemiol; 1995 Mar; 48(3):389-405. PubMed ID: 7897460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. POSCH Group.
    Matts JP; Karnegis JN; Campos CT; Fitch LL; Johnson JW; Buchwald H
    J Fam Pract; 1993 May; 36(5):497-503. PubMed ID: 8482933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.